Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.


Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
04 05 2019
Historique:
received: 01 07 2018
pubmed: 23 10 2018
medline: 21 3 2020
entrez: 23 10 2018
Statut: ppublish

Résumé

This study sought to re-estimate the cumulative incidence of perianal or rectovaginal fistulas and the associated proctectomy rate in the prebiologic era vs the biologic era using a population-based cohort of Crohn's disease (CD) patients. The medical records of 414 residents of Olmsted County, Minnesota, who were diagnosed with CD between 1970 and 2010 were reviewed. The cumulative incidence of perianal or rectovaginal fistulas from time of CD diagnosis and the cumulative rate of proctectomy from date of first perianal or rectovaginal fistula diagnosis were estimated using the Kaplan-Meier method. Eighty-five patients (20.5%) diagnosed with CD between 1970 and 2010 had at least 1 perianal or rectovaginal fistula episode between January 1, 1970, and June 30, 2016. The cumulative incidence of perianal or rectovaginal fistulas was 18% after 10 years, 23% after 20 years, and 24% after 30-40 years from CD diagnosis. The cumulative incidence of perianal or rectovaginal fistulas was significantly lower in patients diagnosed in 1998 or after than in patients diagnosed before 1998 (P = 0.03, log-rank). Among 85 patients developing perianal or rectovaginal fistulas, 16 patients (18.8%) underwent proctectomy for the treatment of perianal or rectovaginal fistulas during follow-up. In a population-based inception cohort of CD, one-fifth of patients were diagnosed with at least 1 perianal or rectovaginal fistula. The cumulative probability of perianal or rectovaginal fistulizing disease has decreased over time.

Sections du résumé

BACKGROUND
This study sought to re-estimate the cumulative incidence of perianal or rectovaginal fistulas and the associated proctectomy rate in the prebiologic era vs the biologic era using a population-based cohort of Crohn's disease (CD) patients.
METHODS
The medical records of 414 residents of Olmsted County, Minnesota, who were diagnosed with CD between 1970 and 2010 were reviewed. The cumulative incidence of perianal or rectovaginal fistulas from time of CD diagnosis and the cumulative rate of proctectomy from date of first perianal or rectovaginal fistula diagnosis were estimated using the Kaplan-Meier method.
RESULTS
Eighty-five patients (20.5%) diagnosed with CD between 1970 and 2010 had at least 1 perianal or rectovaginal fistula episode between January 1, 1970, and June 30, 2016. The cumulative incidence of perianal or rectovaginal fistulas was 18% after 10 years, 23% after 20 years, and 24% after 30-40 years from CD diagnosis. The cumulative incidence of perianal or rectovaginal fistulas was significantly lower in patients diagnosed in 1998 or after than in patients diagnosed before 1998 (P = 0.03, log-rank). Among 85 patients developing perianal or rectovaginal fistulas, 16 patients (18.8%) underwent proctectomy for the treatment of perianal or rectovaginal fistulas during follow-up.
CONCLUSIONS
In a population-based inception cohort of CD, one-fifth of patients were diagnosed with at least 1 perianal or rectovaginal fistula. The cumulative probability of perianal or rectovaginal fistulizing disease has decreased over time.

Identifiants

pubmed: 30346531
pii: 5139601
doi: 10.1093/ibd/izy329
pmc: PMC6505440
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1054-1060

Subventions

Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States

Informations de copyright

© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

N Engl J Med. 1999 May 6;340(18):1398-405
pubmed: 10228190
Gastroenterology. 2002 Apr;122(4):875-80
pubmed: 11910338
Am J Epidemiol. 2011 May 1;173(9):1059-68
pubmed: 21430193
Eur J Gastroenterol Hepatol. 2017 May;29(5):595-601
pubmed: 28350751
Cell Transplant. 2013;22(2):279-85
pubmed: 23006344
United European Gastroenterol J. 2015 Aug;3(4):335-42
pubmed: 26279841
Am J Gastroenterol. 1998 Mar;93(3):442-8
pubmed: 9517654
Aliment Pharmacol Ther. 2003 May 1;17(9):1145-51
pubmed: 12752351
Gastroenterology. 2003 Aug;125(2):380-8
pubmed: 12891539
Ann Surg. 1938 Nov;108(5):867-73
pubmed: 17857277
N Engl J Med. 2004 Feb 26;350(9):876-85
pubmed: 14985485
Gut. 1980 Jun;21(6):525-7
pubmed: 7429313
J Crohns Colitis. 2016 Jul;10(7):758-65
pubmed: 26826183
Gastroenterology. 2010 Oct;139(4):1147-55
pubmed: 20637205
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863
pubmed: 27856364
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
Gut. 2014 Sep;63(9):1381-92
pubmed: 24951257
Gastroenterology. 2017 Jul;153(1):59-62.e2
pubmed: 28400193
Dis Colon Rectum. 2011 May;54(5):579-85
pubmed: 21471759
Am J Gastroenterol. 2010 Feb;105(2):289-97
pubmed: 19861953
Scand J Gastroenterol. 2010 Oct;45(10):1178-85
pubmed: 20560811
Mayo Clin Proc. 2012 Dec;87(12):1202-13
pubmed: 23199802
Curr Opin Gastroenterol. 2017 Jul;33(4):246-253
pubmed: 28463854
Gut. 2001 Dec;49(6):777-82
pubmed: 11709511
Inflamm Bowel Dis. 2007 Mar;13(3):254-61
pubmed: 17206702
Gastroenterology. 2006 Mar;130(3):650-6
pubmed: 16530505
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Gastroenterology. 1998 Jun;114(6):1161-8
pubmed: 9609752
N Engl J Med. 1980 May 1;302(18):981-7
pubmed: 6102739
Am J Gastroenterol. 2012 Nov;107(11):1693-701
pubmed: 22945286
Int J Epidemiol. 2012 Dec;41(6):1614-24
pubmed: 23159830
Lancet. 2016 Sep 24;388(10051):1281-90
pubmed: 27477896
Stem Cells. 2013 Nov;31(11):2575-81
pubmed: 23404825
Int J Colorectal Dis. 2013 Mar;28(3):313-23
pubmed: 23053677
Dis Colon Rectum. 2009 Jan;52(1):79-86
pubmed: 19273960
Dig Liver Dis. 2007 Oct;39(10):963-9
pubmed: 17720635
Scand J Gastroenterol. 2015 Feb;50(2):188-96
pubmed: 25515241
Dis Colon Rectum. 2005 Jul;48(7):1416-23
pubmed: 15933795

Auteurs

Sang Hyoung Park (SH)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Satimai Aniwan (S)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Division of Gastroenterology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

W Scott Harmsen (W)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

William J Tremaine (WJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Amy L Lightner (AL)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

William A Faubion (WA)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Edward V Loftus (EV)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH